Gordon Dunn - Sep 9, 2024 Form 4 Insider Report for Quoin Pharmaceuticals, Ltd. (QNRX)

Role
Chief Financial Officer
Signature
/s/ Gordon Dunn
Stock symbol
QNRX
Transactions as of
Sep 9, 2024
Transactions value $
$23,205
Form type
4
Date filed
9/11/2024, 04:30 PM
Previous filing
Oct 30, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction QNRX Ordinary Shares Purchase $685 +856 $0.80 856 Sep 9, 2024 Direct F1
transaction QNRX Ordinary Shares Purchase $3.12K +4K +467.29% $0.78 4.86K Sep 9, 2024 Direct F1
transaction QNRX Ordinary Shares Purchase $3.2K +4K +82.37% $0.80 8.86K Sep 9, 2024 Direct F1
transaction QNRX Ordinary Shares Purchase $9.1K +10K +112.92% $0.91 18.9K Sep 10, 2024 Direct F1
transaction QNRX Ordinary Shares Purchase $7.1K +10K +53.03% $0.71 28.9K Sep 10, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reported securities are represented by American Depositary Shares ("ADSs"). Each ADS represents one ordinary shares of the Issuer.